Overall, the results are indicative for a high receptor binding and internalization of 68Ga-PSMA-11 and 18F-PSMA-1007 in prostate tumors and metastases, which may have potential applications in the field of PSMA radioligand therapy. Here, FOLH1 is linked to prostate neoplasm.